CGON
Price
$42.61
Change
+$1.24 (+3.00%)
Updated
Dec 3 closing price
Capitalization
3.44B
Intraday BUY SELL Signals
OCS
Price
$19.02
Change
+$0.23 (+1.22%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
1.1B
Intraday BUY SELL Signals
Interact to see
Advertisement

CGON vs OCS

Header iconCGON vs OCS Comparison
Open Charts CGON vs OCSBanner chart's image
CG Oncology
Price$42.61
Change+$1.24 (+3.00%)
Volume$1.05M
Capitalization3.44B
Oculis Holding AG
Price$19.02
Change+$0.23 (+1.22%)
Volume$3.01K
Capitalization1.1B
CGON vs OCS Comparison Chart in %
CGON
Daily Signal:
Gain/Loss:
OCS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CGON vs. OCS commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Hold and OCS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (CGON: $41.37 vs. OCS: $18.78)
Brand notoriety: CGON and OCS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 41% vs. OCS: 49%
Market capitalization -- CGON: $3.44B vs. OCS: $1.1B
CGON [@Biotechnology] is valued at $3.44B. OCS’s [@Biotechnology] market capitalization is $1.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileOCS’s FA Score has 0 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • OCS’s FA Score: 0 green, 5 red.
According to our system of comparison, OCS is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 5 TA indicator(s) are bullish while OCS’s TA Score has 4 bullish TA indicator(s).

  • CGON’s TA Score: 5 bullish, 4 bearish.
  • OCS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CGON is a better buy in the short-term than OCS.

Price Growth

CGON (@Biotechnology) experienced а -9.10% price change this week, while OCS (@Biotechnology) price change was -2.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($3.44B) has a higher market cap than OCS($1.1B). CGON YTD gains are higher at: 44.247 vs. OCS (10.471). OCS has higher annual earnings (EBITDA): -106.25M vs. CGON (-157.09M). CGON has more cash in the bank: 661M vs. OCS (160M). CGON (994K) and OCS (1.03M) have identical debt. CGON has higher revenues than OCS: CGON (551K) vs OCS (0).
CGONOCSCGON / OCS
Capitalization3.44B1.1B313%
EBITDA-157.09M-106.25M148%
Gain YTD44.24710.471423%
P/E RatioN/A63.08-
Revenue551K0-
Total Cash661M160M413%
Total Debt994K1.03M97%
TECHNICAL ANALYSIS
Technical Analysis
CGONOCS
RSI
ODDS (%)
N/A
Bearish Trend 7 days ago
37%
Stochastic
ODDS (%)
Bearish Trend 7 days ago
88%
Bullish Trend 7 days ago
45%
Momentum
ODDS (%)
Bullish Trend 7 days ago
69%
Bearish Trend 7 days ago
36%
MACD
ODDS (%)
Bullish Trend 7 days ago
62%
N/A
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
81%
Bearish Trend 7 days ago
50%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
79%
Bearish Trend 7 days ago
50%
Advances
ODDS (%)
Bullish Trend 10 days ago
77%
Bullish Trend 10 days ago
69%
Declines
ODDS (%)
Bearish Trend 30 days ago
80%
Bearish Trend 15 days ago
64%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
54%
Aroon
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 7 days ago
52%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signal:
Gain/Loss:
OCS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBPBX52.90N/A
N/A
Neuberger Berman Large Cap Value Adv
LMSAX41.72N/A
N/A
ClearBridge Small Cap A
DSCYX34.54N/A
N/A
BNY Mellon Opportunistic Small Cap Y
FMIUX37.58N/A
N/A
FMI Common Stock Institutional
AXVNX19.45N/A
N/A
Acclivity Small Cap Value N

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with SYRE. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
-4.35%
SYRE - CGON
58%
Loosely correlated
-0.91%
ACLX - CGON
57%
Loosely correlated
-2.03%
IDYA - CGON
56%
Loosely correlated
-1.75%
NUVL - CGON
55%
Loosely correlated
-1.37%
XNCR - CGON
54%
Loosely correlated
-3.15%
More

OCS and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCS has been loosely correlated with CGEN. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if OCS jumps, then CGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCS
1D Price
Change %
OCS100%
-1.16%
CGEN - OCS
34%
Loosely correlated
-0.33%
SNSE - OCS
32%
Poorly correlated
-1.17%
GRI - OCS
30%
Poorly correlated
-1.02%
PRAX - OCS
29%
Poorly correlated
-2.73%
CGON - OCS
29%
Poorly correlated
-4.35%
More